디앤디파마텍으로 생각해볼만한게 ‘Late-Breaking Abstract(LBA)’로 선정되었는데.. 펩트론도 LBA선정됫자나요??? 기대감가져보자구요
❤74👍25⚡5🥰3🔥2
Signed 리써처TV 바이오 Insight

Channel
@researchertv
On this record: Growth · Engagement · What this channel posts · Reactions · Posts · Citations · Cite this entry
8,208subscribers
-53 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of 3,162–10,000.
| Telegram ID | -1002632411878 |
|---|---|
| Type | Channel |
| Username | @researchertv |
| Created | Between 1 March 2025 and 31 July 2025— estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 7 August 2026 |
| Last confirmed live | 16 August 2026 |
| Measurements held | 5 |
| Confirmed unchanged | 1 time, most recently 16 August 2026 |
| On Telegram | t.me/researchertv |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 16 Aug 2026, 14:25 | 8,208 | -11 |
| 12 Aug 2026, 20:06 | 8,219 | -28 |
| 10 Aug 2026, 04:43 | 8,247 | -13 |
| 7 Aug 2026, 13:54 | 8,260 | -1 |
| 7 Aug 2026, 10:31 | 8,261 | first reading |
20 posts held, back to 19 February 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 12 pagesof Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 27 May 2026. An engagement rate over an empty window would be a number about nothing.
Lifetime counters from Telegram’s own channel header, read 18 August 2026 — not the date at the top of this page, which is when the subscriber count was last read. Below Telegram’s rounding threshold, so these counts are exact.
797 reactions across 20 posts, in 15 distinct kinds. The most used accounts for 48.3% of them.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| ❤ | 385 | 48.3% | |
| 👍 | 304 | 38.1% | |
| 🥰 | 30 | 3.76% | |
| 🤝 | 20 | 2.51% | |
| 🙏 | 15 | 1.88% | |
| 🔥 | 12 | 1.51% | |
| ⚡ | 11 | 1.38% | |
| 🕊 | 6 | 0.753% | |
| ✍ | 3 | 0.376% | |
| 🎉 | 3 | 0.376% | |
| 👏 | 2 | 0.251% | |
| 😁 | 2 | 0.251% | |
| 😎 | 2 | 0.251% | |
| 💋 | 1 | 0.125% | |
| 💯 | 1 | 0.125% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 20 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 797reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 20 most recent posts we hold, published 19 February 2026 to 27 May 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
디앤디파마텍으로 생각해볼만한게 ‘Late-Breaking Abstract(LBA)’로 선정되었는데.. 펩트론도 LBA선정됫자나요??? 기대감가져보자구요
❤74👍25⚡5🥰3🔥2
Signed 리써처TV 바이오 Insight
Photo, posted without a caption
❤14👍2
Signed 리써처TV 바이오 Insight
에이프릴바이오 21년 에이프릴바이오<-->룬드벡 APB-A1(=CD40L) 기술수출함 갑상선안병증(TED) 임상 1b상 진행중임 26년 6월13~16일 미국 시카고에서 열리는 세계 내분비학회(ENDO 2026)에서 1b상 데이터 공개 예정임 데이터는 긍정적인것으로 추정 가능함 왜? 룬드벡은 이미 APB-A1(=CD40L) 연내 임상 2상 개시 결정한 상태임 추가적으로 암젠 다조달리베프(=CD40) 쇼그렌 증후군 임상 3상 성공시 에이프릴바이오 파이프라인 가치 부각될 것으로 판단함 6월에 이벤트 기대감 연말에 암젠 동종 파이프라인 기대감 에이프릴바이오 중장기관점 관심유효
❤30👍7
Signed 리써처TV 바이오 Insight
https://www.youtube.com/watch?v=BgoFf6mQw5w
👍20❤3
Signed 리써처TV 바이오 Insight
넥스트바이오메디컬<->아사히힌텍 일본판권 deal 체결
👍47✍2❤2
Signed 리써처TV 바이오 Insight
https://www.nikkei.com/nkd/disclosure/tdnr/20260409500913/
❤13
Signed 리써처TV 바이오 Insight
큐리옥스바이오시스템즈IR + 넥스트바이오메디컬IR + 인벤티지랩IR 참여하셔서 녹취원본있으시다면.. [email protected] 보내주시면 감사합니다..
❤17🔥7👍5✍1
Signed 리써처TV 바이오 Insight
Photo, posted without a caption
❤23👍18⚡3
Signed 리써처TV 바이오 Insight
Photo, posted without a caption
👍28❤7🕊1
Signed 리써처TV 바이오 Insight
Photo, posted without a caption
👍31❤5💋1
Signed 리써처TV 바이오 Insight
Photo, posted without a caption
👍30🎉3
Signed 리써처TV 바이오 Insight
인투셀 SB303(=Nectin4) 전임상 데이터 공개 예정 링커 인투셀 + 페이로드 중국 프론트라인 바이오파마 TOP1저해제 적용함 전임상이긴 하지만 데이터가 긍정적으로 나올 시 링커 기술력 입증하는 과정이라고 생각하면됨. 너무열광보다는 일하는정도로 인지. 삼성바이오에피스가 메인파이프라인으로 인투셀 링커를 선택한만큼 기술력 입증 기대감 유효. 인투셀 자체 파이프라인 B7-H3 FDA 임상 1상중임 최초 인체 데이터이고 이 데이터가 잘나올 시 주가 레벨업 기대 데이터 기대감은 하반기로 추정함 https://www.biospectator.com/news/view/28134
❤33👍5
Signed 리써처TV 바이오 Insight
Showing the 12 most recent of 20 posts we hold for @researchertv. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Citation-graph rank — 1,051,437 of 1,549,376entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 16 August 2026 — this entry's latest reading, not the date you are reading this.
“리써처TV 바이오 Insight” (@researchertv), 8,208 subscribers as measured 16 August 2026. Telegram Register, tgregister.com/channel/researchertv.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.